NCT02688907 |
|
Phase II Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation
|
View
|
NCT02593019 |
|
Phase II Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients
|
View
|
NCT05262400 |
|
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With PF-07104091 In Participants With Breast Cancer and Solid Tumors
|
View
|
NCT05735080 |
|
Open-Label Study to Evaluate the Safety Tolerability PK and Efficacy of INX-315 in Patients with Advanced Cancer
|
View
|
NCT05759676 |
|
Efficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the Diabetes
|
View
|
NCT05431153 |
|
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
|
View
|
NCT06264921 |
|
A Study With NKT3447 for Adults With AdvancedMetastatic Solid Tumors
|
View
|
NCT06586957 |
|
A Study with NKT3964 for Adults with AdvancedMetastatic Solid Tumors
|
View
|
NCT05905341 |
|
Study of PF-07224826 as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors
|
View
|
NCT06257264 |
|
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
|
View
|
NCT05252416 |
|
VELA Study of BLU-222 in Advanced Solid Tumors
|
View
|